Toward Eclipse Mapping of Hot Jupiters

Recent Spitzer infrared measurements of hot Jupiter eclipses suggest that eclipse mapping techniques could be used to spatially resolve the day-side photospheric emission of these planets using partial occultations. As a first step in this direction, we simulate ingress/egress lightcurves for the three brightest known eclipsing hot Jupiters and evaluate the degree to which parameterized photospheric emission models can be distinguished from each other with repeated, noisy eclipse measurements. We find that the photometric accuracy of Spitzer is insufficient to use this tool effectively. On the other hand, the level of photospheric details that could be probed with a few JWST eclipse measurements could greatly inform hot Jupiter atmospheric modeling efforts. A JWST program focused on non-parametric eclipse map inversions for hot Jupiters should be actively considered.Comment: 32 pages, 6 figures, 3 tables, accepted for publication in Ap

IP Pegasi: Investigation of the accretion disk structure. Searching evidences for spiral shocks in the quiescent accretion disk

We present the results of spectral investigations of the cataclysmic variable IP Peg in quiescence. Optical spectra obtained on the 6-m telescope at the Special Astrophysical Observatory (Russia), and on the 3.5-m telescope at the German-Spanish Astronomical Center (Calar Alto, Spain), have been analysed by means of Doppler tomography and Phase Modelling Technique. From this analysis we conclude that the quiescent accretion disk of IP Peg has a complex structure. There are also explicit indications of spiral shocks. The Doppler maps and the variations of the peak separation of the emission lines confirm this interpretation. We have detected that all the emission lines show a rather considerable asymmetry of their wings varying with time. The wing asymmetry shows quasi-periodic modulations with a period much shorter than the orbital one. This indicates the presence of an emission source in the binary rotating asynchronously with the binary system. We also have found that the brightness of the bright spot changes considerably during one orbital period. The spot becomes brightest at an inferior conjunction, whereas it is almost invisible when it is located on the distant half of the accretion disk. Probably, this phenomenon is due to an anisotropic radiation of the bright spot and an eclipse of the bright spot by the outer edge of the accretion disk.Comment: 13 pages, 11 figures (= 21 EPS files), accepted for publication in A&

Selectivity of Relative Humidity Using a CP Based on S-Block Metal Ions

Herein, we present the syntheses of a novel coordination polymer (CP) based on the perylene-3,4,9,10-tetracarboxylate (pery) linkers and sodium metal ions. We have chosen sodium metal center with the aim of surmising the effect that the modification of the metal ion may have on the relative humidity (RH) experimental measurements of the material. We confirm the role of the ions in the functionalization of the deposited layer by modifying their selectivity towards moisture content, paving the way to the generation of sensitive and selective chemical sensors.This work is part of the I+D+I projects PGC2018-102052-A-C22, PGC2018-102052-B-C21, PID2020-117344R-I00 and CTQ-2015-64049-C3-3R, supported by the MCIN/AEI/10.13039/501100011033/ (FEDER: A way to make Europe), Junta de Andalucía (FQM-394, P20_00265 and B-FQM-734-UGR20). It also has been supported by the European Commission through the fellowship H2020-MSCA-IF-2017 794885-SELFSENS.Peer reviewe

Spectral mapping of the spiral structures in IP Pegasi on the decline from an outburst

(abridged) We report eclipse mapping of time resolved spectroscopy of the dwarf nova IP Pegasi on the late decline from the May 1993 outburst. The spiral arms are still visible some 8 days after the onset of the outburst. Their fractional contribution to the continuum emission is similar to that measured close to outburst maximum, whereas their orientation is rotated by 58 degrees with respect to the spirals seen in the eclipse map at outburst maximum. Velocity-resolved light curves across the Halpha and the HeI lines show the classical rotational disturbance, with the blue side of the line being eclipsed earlier than the red side. The differences between the Halpha and the HeI maps are significant. The spiral arms are clearly seen in the HeI maps, with the receding arm being stronger in the red side while the approaching arm is stronger in the blue side of the line. The analysis of the Halpha maps suggests that this emission arises mainly from a large and vertically-extended region which we interpret as an outflowing (and spiraling) disc wind. The spectrum of the uneclipsed light is dominated by a strong, blueshifted and narrow Halpha emission line superimposed on a red continuum and can be understood as a combination of emission from an M5V secondary star plus optically thin emission from the outer parts of the vertically-extended disc wind. The inner disc regions show an emission line spectrum with a strong and broad Halpha component superimposed on a flat continuum. This is in marked contrast with the results from the spectral mapping of nova-like variables of comparable inclination and mass ratio and suggests that intrinsically different physical conditions hold in the inner disc regions of outbursting dwarf novae and nova-like systems.Comment: To appear in Mon. Not. R. Ast. Soc., 12 pages, 10 figures, coded with MNRAS latex styl

Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage

Background and Purpose: Stroke-associated immunosuppression and inflammation are increasingly recognized as factors that trigger infections and thus, potentially influence the outcome after stroke. Several studies demonstrated that elevated neutrophil-to-lymphocyte ratio (NLR) is a significant predictor of adverse outcomes in patients with ischemic stroke. However, little is known about the impact of NLR on short-term mortality in intracerebral hemorrhage (ICH). Methods: This observational study included 855 consecutive ICH-patients. Patient demographics, clinical, laboratory, and in-hospital measures as well as neuroradiological data were retrieved from institutional databases. Functional 3-months-outcome was assessed and categorized as favorable (modified Rankin Scale [mRS] 0-3) and unfavorable (mRS 4-6). We (i) studied the natural course of NLR in ICH, (ii) analyzed parameters associated with NLR on admission (NLROA), and (iii) evaluated the clinical impact of NLR on mortality and functional outcome. Results: The median NLROA of the entire cohort was 4.66 and it remained stable during the entire hospital stay. Patients with NLR ≥4.66 showed significant associations with poorer neurological status (National Institute of Health Stroke Scale [NIHSS] 18 [9-32] vs. 10 [4-21]; p 2.606 - presented with a better clinical status (NIHSS 12 [5-21] vs. 15 [6-28]; p = 0.005), lower hematoma volumes on admission (10.6 [3.6-30.1] vs. 15.1 [5.7-42.3] mL; p = 0.004) and showed a better functional outcome (3 months mRS 0-3: 82/214 [38.3%] vs. 185/641 [28.9%]; p = 0.009). Patients associated with high NLR (≥8.508 = above 75th-percentile) showed the worst neurological status on admission (NIHSS 21 [12-32] vs. 12 [5-23]; p < 0.001), larger hematoma volumes (21.0 [8.6-48.8] vs. 12.2 [4.1-34.9] mL; p < 0.001), and higher proportions of unfavorable functional outcome at 3 months (mRS 4-6: 173/214 vs. 418/641; p < 0.001). Further, NLR was linked to more frequently occurring infectious complications (pneumonia 107/214 vs. 240/641; p = 0.001, sepsis: 78/214 vs. 116/641; p < 0.001), and increased c-reactive-protein levels on admission (p < 0.001; R2 = 0.064). Adjusting for the above-mentioned baseline confounders, multivariable logistic analyses revealed independent associations of NLROA with in-hospital mortality (OR 0.967, 95% CI 0.939-0.997; p = 0.029). Conclusions: NLR represents an independent parameter associated with increased mortality in ICH patients. Stroke physicians should focus intensely on patients with increased NLR, as these patients appear to represent a population at risk for infectious complications and increased short-mortality. Whether these patients with elevated NLR may benefit from a close monitoring and specially designed therapies should be investigated in future studies

Roche tomography of cataclysmic variables - II. Images of the secondary stars in AM Her, QQ Vul, IP Peg and HU Aqr

We present a set of Roche tomography reconstructions of the secondary stars in the cataclysmic variables AM Her, QQ Vul, IP Peg and HU Aqr. The image reconstructions show distinct asymmetries in the irradiation pattern for all four systems that can be attributed to shielding of the secondary star by the accretion stream/column in AM Her, QQ Vul and HU Aqr, and increased irradiation by the bright-spot in IP Peg. We use the entropy landscape technique to derive accurate system parameters (M1, M2, i and γ) for the four binaries. In principle, this technique should provide the most reliable mass determinations available, since the intensity distribution across the secondary star is known. We also find that the intensity distribution can systematically affect the value of γ derived from circular orbit fits to radial velocity variations

Age-dependent clinical outcomes in primary versus oral anticoagulation-related intracerebral hemorrhage

Aims This study determined the influence of age on bleeding characteristics and clinical outcomes in primary spontaneous (non-OAC), vitamin K antagonist-related (VKA-) and non-vitamin K antagonist oral anticoagulant-related (NOAC-) ICH. Methods Pooled individual patient data of multicenter cohort studies were analyzed by logistic regression modelling and propensity-score-matching (PSM) to explore the influence of advanced age on clinical outcomes among non-OAC-, VKA-, and NOAC-ICH. Primary outcome measure was functional outcome at three months assessed by the modified Rankin Scale, dichotomized into favorable (mRS = 0–3) and unfavorable (mRS = 4–6) functional outcome. Secondary outcome measures included mortality, hematoma characteristics, and frequency of invasive interventions. Results In VKA-ICH 33.5% (670/2001), in NOAC-ICH 44.2% (69/156) and in non-OAC-ICH 25.2% (254/1009) of the patients were ≥80 years. After adjustment for treatment interventions and relevant parameters, elderly ICH patients comprised worse functional outcome at three months (adjusted odds ratio (aOR) in VKA-ICH: 1.49 (1.21–1.84); p < 0.001; NOAC-ICH: 2.01 (0.95–4.26); p = 0.069; non-OAC-ICH: 3.54 (2.50–5.03); p < 0.001). Anticoagulation was significantly associated with worse functional outcome below the age of 70 years, (aOR: 2.38 (1.78–3.16); p < 0.001), but not in patients of ≥70 years (aOR: 1.21 (0.89–1.65); p = 0.217). The differences in initial ICH volume and extent of ICH enlargement between OAC-ICH and non-OAC-ICH gradually decreased with increasing patient age. Conclusions As compared to elderly ICH-patients, in patients <70 years OAC-ICH showed worse clinical outcomes compared to non-OAC-ICH because of larger baseline ICH-volumes and extent of hematoma enlargement. Treatment strategies aiming at neutralizing altered coagulation should be aware of these findings

PenQuest Volume 1, Number 2

Table of Contents for this Volume: Untitled by Julie Ambrose Night by Judith Gallo Untitled by Judy Gozdur the shamans by Charles Riddles Untitled by Jerry Connell Untitled by Laura Woods Untitled by LEMA Wicked Bird by Laura Jo Last Untitled by Rick Dentos Untitled by Jeni Moody Untitled by Bettie W. Kwibs Untitled by Joann Stagg The Protector Stood by Laura Jo Last Visions of Salome by Charles Riddles Untitled by Thomas Tutten Kennesaw Line by Don Ova-Dunaway Stone Blood by Mary Ellen C. Wofford Untitled by Roger Whitt Jr. Untitled by C. Wingate Untitled by Doug Dorey Untitled by Karen Blumberg Untitled by Beverly Oviatt Untitled by Virginia Shrader The Crapulous Credo of Charles C. by Charles Riddles the brave and the true by David Reed Untitled by Charles Gutierrez Canoe Creek by Patricia Kraft Untitled by Linda Bobinger The Man in the Iron Lung by Patricia Kraft Untitled by Roger Whitt, Jr. Childish Things by Kathleen Gay Untitled by Joseph Avanzini The Lover by Mary S. Aken Untitled by Ann Harrington And He Taketh Away by David Reed Untitled by Mary Graham Untitled by Melody A. Cummons Untitled by Karen Blumberg To The Poets by Judith Gallo Untitled by Ann Harringto

Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

Background: Patients who have had a stroke with unknown time of onset have been previously excluded from thrombolysis. We aimed to establish whether intravenous alteplase is safe and effective in such patients when salvageable tissue has been identified with imaging biomarkers. Methods: We did a systematic review and meta-analysis of individual patient data for trials published before Sept 21, 2020. Randomised trials of intravenous alteplase versus standard of care or placebo in adults with stroke with unknown time of onset with perfusion-diffusion MRI, perfusion CT, or MRI with diffusion weighted imaging-fluid attenuated inversion recovery (DWI-FLAIR) mismatch were eligible. The primary outcome was favourable functional outcome (score of 0–1 on the modified Rankin Scale [mRS]) at 90 days indicating no disability using an unconditional mixed-effect logistic-regression model fitted to estimate the treatment effect. Secondary outcomes were mRS shift towards a better functional outcome and independent outcome (mRS 0–2) at 90 days. Safety outcomes included death, severe disability or death (mRS score 4–6), and symptomatic intracranial haemorrhage. This study is registered with PROSPERO, CRD42020166903. Findings: Of 249 identified abstracts, four trials met our eligibility criteria for inclusion: WAKE-UP, EXTEND, THAWS, and ECASS-4. The four trials provided individual patient data for 843 individuals, of whom 429 (51%) were assigned to alteplase and 414 (49%) to placebo or standard care. A favourable outcome occurred in 199 (47%) of 420 patients with alteplase and in 160 (39%) of 409 patients among controls (adjusted odds ratio [OR] 1·49 [95% CI 1·10–2·03]; p=0·011), with low heterogeneity across studies (I2=27%). Alteplase was associated with a significant shift towards better functional outcome (adjusted common OR 1·38 [95% CI 1·05–1·80]; p=0·019), and a higher odds of independent outcome (adjusted OR 1·50 [1·06–2·12]; p=0·022). In the alteplase group, 90 (21%) patients were severely disabled or died (mRS score 4–6), compared with 102 (25%) patients in the control group (adjusted OR 0·76 [0·52–1·11]; p=0·15). 27 (6%) patients died in the alteplase group and 14 (3%) patients died among controls (adjusted OR 2·06 [1·03–4·09]; p=0·040). The prevalence of symptomatic intracranial haemorrhage was higher in the alteplase group than among controls (11 [3%] vs two [&lt;1%], adjusted OR 5·58 [1·22–25·50]; p=0·024). Interpretation: In patients who have had a stroke with unknown time of onset with a DWI-FLAIR or perfusion mismatch, intravenous alteplase resulted in better functional outcome at 90 days than placebo or standard care. A net benefit was observed for all functional outcomes despite an increased risk of symptomatic intracranial haemorrhage. Although there were more deaths with alteplase than placebo, there were fewer cases of severe disability or death. Funding: None